In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1652-1655

  Robledo, Sara ^a,b   Osorio, Edison ^a   Muñoz, Diana ^a   Jaramillo, Luz Marina ^a   Restrepo, Adriana ^a   Arango, Gabriel ^a   Vélez, Iván ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b Lab 632   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; MEGLUMINE ANTIMONATE; THYMOL; THYMOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HAMSTER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA PANAMENSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; CRICETINAE; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PARASITIC SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; TERPENES; THYMOL; U937 CELLS;

EID: 16244411071     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1652-1655.2005     Document Type: Article

References (19)

1. Aeschbach, R., J. Loliger, B. C. Scott, A. Murcia, J. Butler, B. Halliwell, and O. I. Aruoma. 1994. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem. Toxicol. 32:31-36.
2. Castro, C., M. Jiménez, and M. González. 1992. Inhibitory effect of piquerol A on the growth of epimastisotes of Trypanosoma crutzi. Planta Med. 58:281-282.
3. Cenas, N., A. Nemeikaite, E. Sergediene, H. Nivinskas, Z. Anusevicius, and J. Sarlauskas. 2001. Quantitative structure activity relationships in enzymatic single-electron reduction of nitroaromatic explosives: implications for the cytotoxicity. Biochim. Biophys. Acta 1528:31-38.
4. Chulay, J., L. Fleckenstein, and D. Smith. 1988. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans. R. Soc. Trop. Med. Hyg. 82:69-72.
5. Delnias, F., C. Di Giorgio, M. Robin, N. Azas, M. Gasquet, C. Detang, M. Costa, P. Timon-David, and J. P. Galy. 2002. In vitro activities of position 2 substitution-bearing 6-nitro- and 6-amino-benzothiazoles and their corresponding anthranilic acid derivatives against Leishmania infantum and Trichomonas vaginalis. Antimicrob. Agents Chemother. 46:2588-2594.
6. Didry, N., L. Dubreuil, and M. Pinkas. 1994. Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharm. Acta Helv. 69:25-28.
7. Finney, J. D. 1971. Probit analysis: statistical treatment of the sigmoid response curve. 3rd ed. Cambridge University Press, Cambridge, United Kingdom.
8. Hocquemiller, R., D. Cortes, G. Arango, S. Myint, A. Cave, A. Angelo, V. Munoz, and A. Fournet, 1991. Isolement et synthèse de l'espintanol, nouveau monoterpene antiparasitaire. J. Nat. Prod. 54:445-452.
9. Kayser, O., and A. Kiderlen. 2003. Delivery strategies for antiparasities. Exp. Opin. Investig. Drugs 12:197-207.
10. Kulevanova, S., A. Kaftandzieva, A. Dimitrovska, G. Stefkov, T. Grdanoska, and N. Panovski. 2000. Investigation of antimicrobial activity of essential oils of several Macedonian Thymus L. species (Lamiaceae). Boll. Chim. Farm. 139:276-280.
11. Mikus, J., M. Harkenthal, D. Steverding, and J. Reichling. 2000. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med. 66:366-368.
12. Ogaard, B., E. Larsson, R. Glans, T. Henriksson, and D. Birkhed. 1997. Antimicrobial effect of a chlorhexidine-thymol varnish (Cervitec) in orthodontic patients. A prospective, randomized clinical trial. J. Orofac. Orthop. 58:206-213.
13. Osorio, Y., P. C. Melby, C. Primes, B. Chandrasekar, N. Guarin, and B. Travi. 2003. The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis. Parasite Immunol. 25:139-148.
14. Rhayour, K., T. Bouchikhi, A. Tantaoui Elaraki, K. Sendide, and A. Reromal. 2003. The mechanism of bactericidal action of oregano and clove essential oils and of their phenolic major components on Escherichia coli and Bacillus subtilis. J. Essent. Oil Res. 15:286-292.
15. Robledo, S., A. Valencia, and N. Saravia. 1999. Sensitivity to Glucantime of Leishmania Viannia isolated from patients prior to treatment. J. Parasitol. 85:360-366.
16. Shapiro, S., and B. Guggenheim. 1995. The action of thymol on oral bacteria. Oral Microbiol. Immunol. 10:241-246.
17. Travi, B., J. E. Martínez, and A. Zea. 1993. Antimonial treatment of hamsters infected with Leishmania (V.) panamensis: assessment of parasitological cure with different therapeutic schedules. Trans. R. Soc. Trop. Med. Hyg. 87:567-569.
18. Travi, B., Y. Osorio, P. C. Melby, B. Chandrasekar, L. Arteaga, and N. Saravia. 2002. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infect. Immun. 70:2288-2296.
19. Weniger, B., S. Robledo, G. Arango, E. Deharo, R. Aragon, V. Munoz, J. Callapa, A. Lobstein, and R. Anton. 2001. Antiprotozoal activities from Colombian plants. J. Ethnopharmacol. 78:193-200.